Decision and cost-utility analyses of surgical versus transcatheter closure of patent ductus arteriosus: Should you let a smile be your umbrella?

Medical Decision Making

Volumn 18, Issue 2, 1998, Pages 187-201

  Gray, Darryl T ^a   Weinstein, Milton C ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b NONE

Author keywords

Cost utility analysis; Decision analysis; Ductus arteriosus, patent; Pediatric cardiac surgery; Pediatric cardiology; Pediatrics; Technology assessment, biomedical

Indexed keywords

ARTICLE; COST EFFECTIVENESS ANALYSIS; HEART SURGERY; MEDICAL DECISION MAKING; PATENT DUCTUS ARTERIOSUS; PEDIATRIC SURGERY;

EID: 0031916070     PISSN: 0272989X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0272989X9801800208     Document Type: Article

References (57)

1. Kirklin J, Barralt-Boyes B. Patent ductus artcriosus. In: Kirklin J, Barratt-Boyes B (eds). Cardiac Surgery. 2nd ed. New Yurk: Churchill Livingstone, 1993:841-59.
2. Mavroudis C, Backer CL, Gevitz M. Forty-six years of patent ductus arteriosus division at Children' Memorial Hospital of Chicago. Standards for comparison [review]. Ann Surg. 1994;220:402-9.
3. Rashkind WJ, Cuaso CC. Transcatheter closure of patent ductus arteriosus. Pediatr Cardiol. 1979;1:3-7.
4. Rashkind WJ, Mullins CE, Hellenbrand WE, Tait MA. Non-surgical closure of patent ductus arteriosus. Circulation. 1987;75:583-9.
5. Latson LA, Hofshire PJ, Kugler JD, Cheatham JP, Gumbiner CH, Danforth DA. Transcatheter closure of patent ductus arteriosus in pediatric patients. J Pediatr. 1989;- 115:549-53.
6. Lloyd TR, Fedderly R, YIendelsohn AM, Sandhu SK, Beekman RH III. Transcathetor occlusion of patent ductus arteriosus with Gianturco coils. Circulation. 1993;88(part 1):1412-20.
7. Dyck JD, Benson LN, Smallhorn JF, McLaughlin PR, Freedom RM, Rowe RD. Catheter occlusion of the persistently patent ductus arteriosus. Am J Cardiol. 1988;62:1089-92.
8. Hosking MC, Benson LN, Musewe NN, Dyck JD, Freedom RM. Transcatheter occlusion of the persistently patent ductus arteriosus occluder: forty-month follow-up and prevalence of residual shunting. Circulation. 1991;84:2313-7.
9. Report of the European Registry. Transcatheter occlusion of persistent arterial duct. Lancet. 1992;340:2062-6.
10. Ali Khan MA, Al Yousef j, Mullins CE, Sawyer W. Experience with 205 procedures of transcaihcter closure of ductus arteriosus in 182 patients, with special reference to residual shunts and long-term follow-up. J Thorac Cardiovasc Surg, 1992;104:1721-7.
11. Kassirer JP. The principles of clinical decision making: an introduction to decision analysis. Yale J Biol Med. 1976;49:149-64.
12. Weinstein MC, Fineberg HV, Elstein AS et al (eds). Clinical Decision Analysis. Philadelphia, PA: W. B. Saunders, 1980.
13. Sox HC Jr, Blatt MA, Higgins MC, Marion KI. Medical Decision Making. Boston, MA: Butterworths, 1988.
14. Drummond MF, Stoddart GL, Torrancc GW. Cost-utility analysis. In: Methods for the Economic Evaluation of Health Care Programmes. Oxford, U.K.: Oxford Medical Publications, 1987:112-48.
15. Gray DT, Fyler DC, Walker AM, Weinstein MC, Chalmers TC. Clinical outcomes and costs of transcatheter as compared with surgical closure of patent ductus arteriosus. N Engl J Med. 1993;329:1517-23.
16. Finkler S. The distinction between cost and charges. Ann Intern Med. 1982;96:102-9.
17. Transition Systems, Inc. Product Line Manager: Sample Reports. Boston, MA: Transitional Systems, 1988.
18. Gray DT. Cost effectiveness analysis of interventions for congenital heart disease. J Interven Cardiol, 1995;8:1-19.
19. Gray DT. The application of epidemiologic methods to the assessment of outcomes in interventional cardiology. J Interven Cardiol. 1997;10:41-50.
20. Read JL, Quinn RJ, Berwick DM, Fineberg HV, Weinstein MC. Preferences for health outcomes. Comparison of assessment methods. Med Decis Making. 1984;4:315-29.
21. Gray DT, Walker AM, Fyler DC, Chalmers TC. Examination of the early 'learning curve' for transcatheter closure of patent ductus arteriosus using the Rashkind occluder. Circulation. 1994;90[part 2]:II-36-II-42.
22. Hollenberg J. SMLTREE Version 2.2 (Decision Analysis Software). Roslyn, NY, 1987.
23. Doubilet P, Begg CB, Weinstein MC, Braun P, McNeil BJ. Probabilistic sensitivity analysis using Monte Carlo simulation. Med Decis Making. 1985;5:157-77.
24. Laupacis A, Feeny D, Detsky AS, Tugwell PX. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. Can Med Assoc J. 1992;146:473-81.
25. Gehan E, Freircich E. Non-randomized controls in cancer clinical triais. N Engl J Med. 1974;290:198-203.
26. Sackett DL. Bias in analytic research, J Chronic Dis. 1979;32:51-63.
27. Hlatky M, Califf RM, Harrell FE Jr, Lee KL, Mark DB, Pryor DB. Comparison of predictions based on observational data with the results of randomized controlled clinical trials of coronary artery bypass surgery. J Am Coll Cardiol. 1988;11:237-45.
28. Greenland S, Neutra R. Control of confounding in the assessment of medical technology. Int J Epidemiol. 1980;9:361-7.
29. Miettinen O. The need for randomization in the study on intended affects. Stat Med. 1983:2:267-71.
30. Parducci A. Contextual effects: a range frequency analysis. In: Cartererte E, Friedman M (eds). Handbook of Perception. New York: Academic Press, 1974.
31. Llewellyn-Thomas H, Sutherland HJ, Tibshirani RF, Ciampi A, Till JE, Boyd NF. The measurement of patients' values in medicine. Med Decis Making. 1982;2:449-62.
32. Keeney RL, Raiffa H. Decisions with Multiple Objectives: Preferences and Value Tradeoffs. New York: Wiley, 1976.
33. Torrance GW. Utility approach to measuring health-related quality of life. J Chronic Dis. 1987;40:593-600.
34. Krischer J. Utility structure of a medical decision-making problem. Oper Res. 1977;24:951-72.
35. Torrance GW, Boyle MH, Horwoocl SP. Application of multiattribute utility theory to measure social preferences for health states. Oper Res. 1982;30:1043-69.
36. Boyle M, Torrance GW, Sinclair JC, Horwood SP. Economic evaluation of neonatal intensive care of very Sow birth-weight infants. X Engl J Med. 1983;308:1330-7.
37. Feeny D, Furlong W, Barr RD, Torrance GW, Rosenboum P, Waltzman S. A comprehensive multi-attribute system for classifying the health status of survivors of childhood cancer. J Clin Oncol. 1992;10:923-8.
38. Holmes MM, Rovner DR, Rothert ML, et al. Women's and physicians' utilities for health outcomes in estrogen replacement therapy. J Gen Intern Med. 1987;2:178-82.
39. Schmitt N, Gogate J, Kothert M, et al. Capturing and clustering women's judgment policies: the case of hormonal therapy for menopause. J Gerontol. 1991;46:92-101.
40. Holzman GB, Ravitch MM, Metheny W, Kothert ML, Holmes M, Hoppe RB. Physicians' judgments about estrogen replacement therapy for menopausal women. Obstet Gynecol. 1984;63:303-11.
41. Elstein AS, Holzman GB, Ravitch MM, et al. Comparison of physicians' decisions regarding estrogen replacement therapy for menopausal women and decisions derived from a decision analytic model. Am J Med. 1986;80:246-58.
42. Llewellyn-Thomas HA, Sutherland ZHJ, Theil EC. Do patients' evaluations of a future health state change when they actually enter that state? Med Care. 1993;31:1002-12.
43. McNeil BJ, Pauker SG, Sox HC Jr, Tversky A. On the elicitation of preferences for alternative therapies. X Engl J Med. 1982;300:1259-62.
44. Fleming WH, Sarafian LB, Kugler JD, Nelson RM Jr. Ligation of parent ductus arteriosus in premature infants: importance of accurate anatomic definition. Pediatrics. 1983;71:373-5.
45. Jones J. Twenty-five years' experience with the surgery of patent ductus arteriosus. J Thorac Cardiovasc Surg. 1965;50:149-68.
46. Ghani SA, Hashim R. Surgical management of patent ductus arteriosus. A review of 413 cases. J R Coll Surg Edinburgh. 1089;34:33-6.
47. Powell CB, Moller JH. Outcomes research using a voluntary generic registry. Progr Pediatr Cardiol. 1997;7:87-90.
48. Gray D, Hewitt P, Chalmers T. The evaluation of surgical therapy. In: Rulkow I (ed). The Socioeconornics of Surgical Health Care Delivery. St. Louis, MO: C. V. Mosby, 1989:228-56.
49. Pagotto LT, Mullins CE, Hellenbrand WE, Latson LA, Cheatharn JP. Cost comparative study of surgical vs transcatheter closure of isolated patent ductus arteriosus (abstr). Circulation. 1994:90:1-642.
50. Human DG, McIntyre L, Gniewek A, Hanna BD. Technology assessment of nonsurgical closure of patent ductus arteriosus: an evaluation of the clinical effectiveness and costs of a new medical device. Pediatrics. 1995;96:703-6.
51. Food and Drug Administration, HHS. Medical devices; investigational devices; interagency agreement between the Food and Drug Administration and the Health Care Financing Administration; categorization of investigational devices for coverage under Medicare; availability. Fed Reg. 1996;61(37):7011-2.
52. Woods JH, Saywell RM, Nyhuis AW, et al. The learning curve and the cost of heart transplantation. Health Serv Res. 1992;27:219-38.
53. Karwande SV, Rowles JR. Simplified muscle-sparing thoracotomy for patent ductus arteriosus ligation in neonates. Ann Thorac Surg. 1992;54:164-5.
54. Rao PS, Sideris EB, Haddad J, et al. Transcathuter occlusion of patent ductus arteriosus with adjustable buttoned device. Initial closure experience. Circulation. 1993;88:1119-26.
55. Bridges ND, Perry SB, Harness I, Keane JF, Lock JE. Transcatheter closure of a large patent ductus arteriosus with the clamshell septal umbrella. J Am Coll Cardiol. 1991;18:1297-302.
56. Laborde F, Noirhomme P, Karam J, Batisse A, Bourel P, Maurice OS. A new video-assisted thoracoscopic surgical technique for interruption of patent ductus arteriosus in infants and children. J Thorac Cardiovasc Surg. 1993;105:278-80.
57. Burke RP, Wernovsky G, van der Veide M, Hansen D, Castaneda AR. Video-assisted thoracoscopic surgery for congenital heart disease. J Thorac Cardiovasc Surg. 1995;109:499-508.